Regulation and Function of the Atypical IκBs—Bcl‐3, IκB NS , and IκBζ—in Lymphocytes and Autoimmunity
European Journal of Immunology · 2025
DOI: 10.1002/eji.202451273 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Immunology, 2025. Verfasst von Tanja Kübelbeck und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University Medical Center of the Johannes Gutenberg-University of Mainz, Mainz, Germany. Hauptthemen laut MEDLINE: Autoimmunity, I-kappa B Proteins, Lymphocytes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Signaling pathways involving NF‐κB transcription factors have essential roles in inflammation, immunity, cell proliferation, differentiation, and survival. Classical IκB proteins, such as IκBα and IκBβ, bind to NF‐κB via ankyrin repeats to sequester NF‐κB in the cytoplasm and thus suppress NF‐κB activity. Unlike these constitutively expressed classical IκBs, the expression of the atypical IκBs Bcl‐3, IκB NS , and IκBζ is induced in immune cells after recognition of antigens, pathogen‐associated molecular patterns (PAMPs) or cytokines, upon which they localize to the nucleus and form complexes with transcription factors and regulators on the DNA. Atypical, nuclear IκBs have been proposed to modulate NF‐κB activity in a context‐dependent manner as they can either inhibit or increase gene expression of a subset of NF‐κB target genes. This complexity may be related to the molecular function of atypical IκBs, which bind to different transcription factor complexes and form a bridge to different cofactors or epigenetic modifiers. Recent research has identified novel target genes of atypical IκBs that include chemokines, cytokines, and master regulators of lymphocyte differentiation, underscoring prominent roles in adaptive immune and autoimmune responses. Here, we summarize our current understanding of atypical IκBs in lymphocytes with a focus on their emerging role in autoimmunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, University Medical Center of the Johannes Gutenberg-University of Mainz, Mainz, Germany.
- Center of Allergy and Environment (ZAUM), Technical University and Helmholtz Zentrum München, Munich, Germany.
- Institute for Immunology, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried, Germany.
- Institute for Molecular Medicine Mainz, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
- Research Centre for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
- Research Unit Molecular Immune Regulation, Molecular Targets and Therapeutics Center, Helmholtz Zentrum München, Munich, Germany.
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Kübelbeck, T., Wichmann, N. O., Raj, T., Raj, C., Ohnmacht, C., Hövelmeyer, N., Kramer, D., & Heissmeyer, V. (2025). Regulation and Function of the Atypical IκBs—Bcl‐3, IκB NS , and IκBζ—in Lymphocytes and Autoimmunity. European Journal of Immunology. https://doi.org/10.1002/eji.202451273
Vancouver
Kübelbeck T, Wichmann NO, Raj T, Raj C, Ohnmacht C, Hövelmeyer N, et al. Regulation and Function of the Atypical IκBs—Bcl‐3, IκB NS , and IκBζ—in Lymphocytes and Autoimmunity. European Journal of Immunology. 2025. doi:10.1002/eji.202451273
BibTeX
@article{Kbelbeck2025,
author = {Kübelbeck, Tanja and Wichmann, Nina Olivera and Raj, Timsse and Raj, Cynthia and Ohnmacht, Caspar and Hövelmeyer, Nadine and Kramer, Daniela and Heissmeyer, Vigo},
title = {Regulation and Function of the Atypical IκBs—Bcl‐3, IκB NS , and IκBζ—in Lymphocytes and Autoimmunity},
journal = {European Journal of Immunology},
year = {2025},
doi = {10.1002/eji.202451273}
}
EUVIMED